State Board of Administration of Florida Retirement System increased its holdings in shares of Amedisys Inc (NASDAQ:AMED) by 0.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 19,658 shares of the health services provider’s stock after acquiring an additional 93 shares during the period. State Board of Administration of Florida Retirement System owned about 0.06% of Amedisys worth $1,235,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of AMED. Ameritas Investment Partners Inc. acquired a new stake in shares of Amedisys during the 1st quarter valued at about $123,000. CIBC Asset Management Inc acquired a new stake in shares of Amedisys during the 2nd quarter valued at about $230,000. SG Americas Securities LLC boosted its position in shares of Amedisys by 48.7% during the 2nd quarter. SG Americas Securities LLC now owns 3,743 shares of the health services provider’s stock valued at $235,000 after acquiring an additional 1,226 shares in the last quarter. Redmile Group LLC acquired a new stake in shares of Amedisys during the 1st quarter valued at about $247,000. Finally, Suntrust Banks Inc. boosted its position in shares of Amedisys by 2.0% during the 1st quarter. Suntrust Banks Inc. now owns 5,465 shares of the health services provider’s stock valued at $279,000 after acquiring an additional 107 shares in the last quarter. Institutional investors and hedge funds own 96.55% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/09/19/state-board-of-administration-of-florida-retirement-system-acquires-93-shares-of-amedisys-inc-amed.html.

In other news, Director Bruce D. Perkins acquired 2,000 shares of Amedisys stock in a transaction on Thursday, August 3rd. The shares were purchased at an average cost of $46.60 per share, for a total transaction of $93,200.00. Following the completion of the purchase, the director now directly owns 15,825 shares of the company’s stock, valued at approximately $737,445. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider David B. Pearce sold 1,000 shares of the stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $50.00, for a total transaction of $50,000.00. Following the sale, the insider now owns 10,488 shares in the company, valued at $524,400. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.

Several analysts have recently weighed in on the stock. Mizuho lowered shares of Amedisys from a “buy” rating to a “neutral” rating and set a $50.00 target price on the stock. in a research report on Wednesday, July 26th. Bank of America Corporation assumed coverage on shares of Amedisys in a research report on Monday, August 21st. They set a “neutral” rating and a $55.00 target price on the stock. BidaskClub upgraded shares of Amedisys from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Royal Bank Of Canada reiterated a “hold” rating and set a $56.00 target price on shares of Amedisys in a research report on Monday, June 5th. Finally, Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $60.00 target price on shares of Amedisys in a research report on Friday. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $56.44.

Amedisys Inc (NASDAQ:AMED) opened at 51.90 on Tuesday. The company’s 50-day moving average is $50.17 and its 200 day moving average is $54.94. The company has a market capitalization of $1.76 billion, a P/E ratio of 44.36 and a beta of 0.84. Amedisys Inc has a one year low of $34.58 and a one year high of $65.91.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Wednesday, July 26th. The health services provider reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.12. The firm had revenue of $378.80 million for the quarter, compared to the consensus estimate of $380.80 million. Amedisys had a net margin of 2.70% and a return on equity of 13.71%. The business’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.42 earnings per share. Analysts predict that Amedisys Inc will post $2.21 EPS for the current year.

Amedisys Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Stock Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related stocks with our FREE daily email newsletter.